These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 39010976)

  • 1. Projecting the economic burden of chronic kidney disease at the patient level (
    Chadban S; Arıcı M; Power A; Wu MS; Mennini FS; Arango Álvarez JJ; Garcia Sanchez JJ; Barone S; Card-Gowers J; Martin A; Retat L
    EClinicalMedicine; 2024 Jun; 72():102615. PubMed ID: 39010976
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Economic Burden Associated with Chronic Kidney Disease: A Pragmatic Review of Medical Costs for the Inside CKD Research Programme.
    Jha V; Al-Ghamdi SMG; Li G; Wu MS; Stafylas P; Retat L; Card-Gowers J; Barone S; Cabrera C; Garcia Sanchez JJ
    Adv Ther; 2023 Oct; 40(10):4405-4420. PubMed ID: 37493856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Projecting the Epidemiological and Economic Impact of Chronic Kidney Disease Using Patient-Level Microsimulation Modelling: Rationale and Methods of Inside CKD.
    Tangri N; Chadban S; Cabrera C; Retat L; Sánchez JJG
    Adv Ther; 2023 Jan; 40(1):265-281. PubMed ID: 36307575
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Projecting the clinical burden of chronic kidney disease at the patient level (
    Chertow GM; Correa-Rotter R; Eckardt KU; Kanda E; Karasik A; Li G; Christiansen CF; Stafylas P; Holt SG; Hagen EC; Garcia Sanchez JJ; Barone S; Cabrera C; Nolan S; Coker T; Webber L; Retat L
    EClinicalMedicine; 2024 Jun; 72():102614. PubMed ID: 39010981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Translating the efficacy of dapagliflozin in chronic kidney disease to lower healthcare resource utilization and costs: a medical care cost offset analysis.
    McEwan P; Hafner M; Jha V; Correa-Rotter R; Chernin G; De Nicola L; Villanueva R; Wheeler DC; Barone S; Nolan S; Garcia Sanchez JJ
    J Med Econ; 2023; 26(1):1407-1416. PubMed ID: 37807895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Projected Health and Economic Burden of Comorbid Gout and Chronic Kidney Disease in a Virtual US Population: A Microsimulation Study.
    Card-Gowers J; Retat L; Kumar A; Marder BA; Padnick-Silver L; LaMoreaux B; Webber L
    Rheumatol Ther; 2024 Aug; 11(4):913-926. PubMed ID: 38836994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An update on the global disparities in kidney disease burden and care across world countries and regions.
    Bello AK; Okpechi IG; Levin A; Ye F; Damster S; Arruebo S; Donner JA; Caskey FJ; Cho Y; Davids MR; Davison SN; Htay H; Jha V; Lalji R; Malik C; Nangaku M; See E; Sozio SM; Tonelli M; Wainstein M; Yeung EK; Johnson DW;
    Lancet Glob Health; 2024 Mar; 12(3):e382-e395. PubMed ID: 38365413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Descriptive study of the economic burden among patients with type 2 diabetes mellitus, chronic kidney disease, and chronic kidney disease and type 2 diabetes mellitus in a large US commercially insured population.
    Chung H; Crowe CL; Kong SX; Singh R; Farej R; Elliott J; Williamson T; Willey VJ
    J Manag Care Spec Pharm; 2023 Jan; 29(1):80-89. PubMed ID: 36580126
    [No Abstract]   [Full Text] [Related]  

  • 9. Informed Dialysis Modality Selection Among Veterans With Advanced CKD: A Community-Level Needs Assessment.
    Chamarthi G; Orozco T; Hale-Gallardo J; Subhash S; Shell P; Pearce K; Jia H; Shukla AM
    Kidney Med; 2024 Jun; 6(6):100832. PubMed ID: 38873241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Burden and Cost of Caring for US Veterans With CKD: Initial Findings From the VA Renal Information System (VA-REINS).
    Saran R; Pearson A; Tilea A; Shahinian V; Bragg-Gresham J; Heung M; Hutton DW; Steffick D; Zheng K; Morgenstern H; Gillespie BW; Leichtman A; Young E; O'Hare AM; Fischer M; Hotchkiss J; Siew E; Hynes D; Fried L; Balkovetz D; Sovern K; Liu CF; Crowley S; ;
    Am J Kidney Dis; 2021 Mar; 77(3):397-405. PubMed ID: 32890592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and Healthcare Resource Use Associated with Risk of Cardiovascular Morbidity in Patients with Chronic Kidney Disease: Evidence from a Systematic Literature Review.
    Darlington O; Dickerson C; Evans M; McEwan P; Sörstadius E; Sugrue D; van Haalen H; Garcia Sanchez JJ
    Adv Ther; 2021 Feb; 38(2):994-1010. PubMed ID: 33432542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early referral strategies for management of people with markers of renal disease: a systematic review of the evidence of clinical effectiveness, cost-effectiveness and economic analysis.
    Black C; Sharma P; Scotland G; McCullough K; McGurn D; Robertson L; Fluck N; MacLeod A; McNamee P; Prescott G; Smith C
    Health Technol Assess; 2010 Apr; 14(21):1-184. PubMed ID: 20441712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost-Effectiveness of Dapagliflozin for Non-diabetic Chronic Kidney Disease.
    Tisdale RL; Cusick MM; Aluri KZ; Handley TJ; Joyner AKC; Salomon JA; Chertow GM; Goldhaber-Fiebert JD; Owens DK
    J Gen Intern Med; 2022 Oct; 37(13):3380-3387. PubMed ID: 35137296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Worldwide Disparity in the Relation Between CKD Prevalence and Kidney Failure Risk.
    van Rijn MHC; Alencar de Pinho N; Wetzels JF; van den Brand JAJG; Stengel B
    Kidney Int Rep; 2020 Dec; 5(12):2284-2291. PubMed ID: 33305122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perceived Health and Quality of Life in Patients With CKD, Including Those With Kidney Failure: Findings From National Surveys in France.
    Legrand K; Speyer E; Stengel B; Frimat L; Ngueyon Sime W; Massy ZA; Fouque D; Laville M; Combe C; Jacquelinet C; Durand AC; Edet S; Gentile S; Briançon S; Ayav C
    Am J Kidney Dis; 2020 Jun; 75(6):868-878. PubMed ID: 31879215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
    de Rooij ENM; de Fijter JW; Le Cessie S; Hoorn EJ; Jager KJ; Chesnaye NC; Evans M; Windahl K; Caskey FJ; Torino C; Szymczak M; Drechsler C; Wanner C; Dekker FW; Hoogeveen EK;
    Am J Kidney Dis; 2023 Sep; 82(3):257-266.e1. PubMed ID: 37182596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Annual health care resource utilization and cost among type 2 diabetes patients with newly recognized chronic kidney disease within a large U.S. administrative claims database.
    Folkerts K; Petruski-Ivleva N; Kelly A; Fried L; Blankenburg M; Gay A; Kovesdy CP
    J Manag Care Spec Pharm; 2020 Dec; 26(12):1506-1516. PubMed ID: 33251992
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.